i meant to comment on a post recently, i think it was Frosty's, and forgot.
The topic of "cures" from ED treatment came up.
In essence, some who try ED treatments such as MUSE and Viagra will be "cured", the reasoning being its psychological ED, the meds do nothing a placebo wouldn't do, and they no longer need the "cure"
If you read the bottom part of this Astra release, you'll see its already been reported as happening.
The Astra press release on its launching of the MUSE product:
Marketletter
Marketletter Publications Ltd. (UK)) Information
Access Company.
Monday, February 23, 1998
UK Launch Of Astra's MUSE
Subscription: 449 British Pound Sterling per year as of 1/97. Published weekly. Contact Marketletter (Publications) Ltd., 54/55 Wilton Rd., London SW1V 1DE, UK.
Astra Pharmaceuticals has launched its transurethral product for the
treatment of male erectile dysfunction of primarily organic etiology,
MUSE (alprostadil), a synthetic form of the vasodilator prostaglandin
E1, in the UK. It was launched in its first market, the USA, in January
last year. A Phase III clinical trial of MUSE, which is licensed from
VIVUS Pharmaceuticals, demonstrated that it was effective in 65.9% of
patients in the clinic, while 64.9% of men in the home treatment phase
achieved intercourse at least once versus 18.6% of placebo receivers.
The recommended starting dose of MUSE is 250mcg, which must be titrated
under medical supervision until the correct dose is found, following
which the patient can use the product at home. Only two doses are
recommended in every 24-hour period. The cost to the National Health
Service for a pack of six MUSE will be L54.84 ($89.37; 125mcg), L59.70
(250mcg and 500mcg) and L61.08 (1,000mcg). It was noted at an Astra
press meeting that there needs to be a shift towards the general
practitioner treating patients with erectile dysfunction. However, John
Pryor, a consultant and urologist, pointed out that the cost of MUSE
"is probably an issue," despite the fact that the treatment has a
significant effect on quality of life and that in practice patients are
quite reasonable with their demand for the product. He also noted that
approximately 7% of men regain spontaneous erection following treatment.
Astra is also the license holder for the rest of Europe, Australia, New
Zealand and South America. |
